Vaxart Inc (NASDAQ:VXRT)
| 4.14 Delayed Data As of Aug 12 |  +0.07 / +1.72%Today’s Change | 2.49 Today|||52-Week Range 9.52 | -33.97% Year-to-Date |
Latest VXRT News | Press Releases
| VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates Aug 08 / Zacks.com - Paid Partner Content | Could This Unknown Stock Beat Moderna in 2023? Aug 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.07 |
| Today’s open | 4.10 |
| Day’s range | 4.01 - 4.16 |
| Volume | 127,981 |
| Average volume (3 months) | 2,702,849 |
| Market cap | $523.1M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -59.00% |
| Earnings growth (this year) | -39.66% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -77.95% |
| P/E ratio | NM |
| Price/Sales | 853.72 |
| Price/Book | 2.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BLUEbluebird bio Inc | +0.40 | +6.34% |
| HRTXHeron Therapeutics I... | +0.43 | +8.83% |
| MGTXMeiraGTx Holdings PL... | +0.71 | +6.77% |
| ATRAAtara Biotherapeutic... | +1.19 | +25.70% |
Data as of 4:00pm ET, 08/12/2022
Financials
| Next reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $892.0K |
| Annual profit (last year) | -$70.5M |
| Net profit margin | -7,900.22% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
